Trulieve Cannabis Corp. (TSE:TRU – Free Report) – Investment analysts at Atb Cap Markets issued their FY2027 earnings estimates for shares of Trulieve Cannabis in a research note issued to investors on Thursday, February 27th. Atb Cap Markets analyst F. Gomes anticipates that the company will post earnings per share of ($0.09) for the year. Atb Cap Markets currently has a “Strong-Buy” rating on the stock. Atb Cap Markets also issued estimates for Trulieve Cannabis’ FY2028 earnings at ($0.07) EPS.
Separately, Craig Hallum upgraded Trulieve Cannabis to a “strong-buy” rating in a research note on Wednesday, February 26th.
Trulieve Cannabis Stock Performance
Insiders Place Their Bets
In other Trulieve Cannabis news, Senior Officer Wes Getman bought 9,500 shares of the stock in a transaction on Friday, December 13th. The shares were acquired at an average price of C$7.02 per share, with a total value of C$66,702.35.
About Trulieve Cannabis
TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
Recommended Stories
- Five stocks we like better than Trulieve Cannabis
- Which Wall Street Analysts are the Most Accurate?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is Short Interest? How to Use It
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How to find penny stocks to invest and tradeĀ
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.